Published: 11 Feb 2025
CRISPR-Cas9 is Revolutionizing AML Treatment as a Novel Therapy
Volume 1
-
Fakhra Alafeefi
Fakhraalafifi@gmail.com -
Afsheen Raza
raza.afsheen@adu.ac.ae
This review explores the progression of CRISPR-Cas9 genome editing technology in gene therapy for acute myeloid leukemia. Acute Myeloid Leukemia, a serious blood cancer, presents formidable treatment obstacles and a dismal prognosis. Effective treatments for acute myeloid leukemia rely on a clear understanding of its intricate genetic mechanisms, and CRISPR-Cas9 technology offers precision and adaptability for targeting the disease’s oncogenic drivers. The dual intron-targeting method of CRISPR-Cas9 is showcased in..